DMD and Duchenne muscular dystrophy: Duchenne muscular dystrophy phenotype variability is influenced by standards of care, therapy with glucocorticoid corticosteroids (GCs), and the genetic architecture of the patient, including the type and location of DMD mutations and genetic modifiers [10,11,12,13].